APA (7th ed.) Citation

T, F., W, Z., N, R., JR, C., & SL, T. (2015). An insulin-sensitizing thiazolidinedione, which minimally activates PPARγ, does not cause bone loss. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 30(3), 481. https://doi.org/10.1002/jbmr.2364

Chicago Style (17th ed.) Citation

T, Fukunaga, Zou W, Rohatgi N, Colca JR, and Teitelbaum SL. "An Insulin-sensitizing Thiazolidinedione, Which Minimally Activates PPARγ, Does Not Cause Bone Loss." Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research 30, no. 3 (2015): 481. https://doi.org/10.1002/jbmr.2364.

MLA (9th ed.) Citation

T, Fukunaga, et al. "An Insulin-sensitizing Thiazolidinedione, Which Minimally Activates PPARγ, Does Not Cause Bone Loss." Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research, vol. 30, no. 3, 2015, p. 481, https://doi.org/10.1002/jbmr.2364.